BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 311617)

  • 1. Strain of Trichomonas vaginalis resistant to metronidazole and other 5-nitroimidazoles.
    Meingassner JG; Thurner J
    Antimicrob Agents Chemother; 1979 Feb; 15(2):254-7. PubMed ID: 311617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A metronidazole-resistant strain of Trichomonas vaginalis and its sensitivity to Go 10213.
    Ray DK; Tendulkar JS; Shrivastava VB; Datta AK; Nagarajan K
    J Antimicrob Chemother; 1984 Oct; 14(4):423-6. PubMed ID: 6334072
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Mtshali A; Ngcapu S; Govender K; Sturm AW; Moodley P; Joubert BC
    Microbiol Spectr; 2022 Aug; 10(4):e0091222. PubMed ID: 35863010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity of Trichomonas vaginalis to metronidazole, tinidazole, and nifuratel in vitro.
    Korner B; Jensen HK
    Br J Vener Dis; 1976 Dec; 52(6):404-8. PubMed ID: 1087577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro effect of tinidazole and furazolidone on metronidazole-resistant Trichomonas vaginalis.
    Narcisi EM; Secor WE
    Antimicrob Agents Chemother; 1996 May; 40(5):1121-5. PubMed ID: 8723451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vitro Testing of Trichomonas vaginalis Drug Susceptibility: Evaluation of Minimal Lethal Concentrations for Metronidazole and Tinidazole That Correspond With Treatment Failure.
    Augostini P; Bradley ELP; Raphael BH; Secor WE
    Sex Transm Dis; 2023 Jun; 50(6):370-373. PubMed ID: 36849257
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Ghosh AP; Aycock C; Schwebke JR
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29439963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro metronidazole and tinidazole activities against metronidazole-resistant strains of Trichomonas vaginalis.
    Crowell AL; Sanders-Lewis KA; Secor WE
    Antimicrob Agents Chemother; 2003 Apr; 47(4):1407-9. PubMed ID: 12654679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Investigation of in vitro metronidazole resistance in the clinical isolates of Trichomonas vaginalis].
    Ertabaklar H; Yaman Karadam S; Malatyalı E; Ertuğ S
    Mikrobiyol Bul; 2016 Oct; 50(4):552-558. PubMed ID: 28124960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug repositioning for novel antitrichomonas from known antiprotozoan drugs using hierarchical screening.
    Meneses-Marcel A; Marrero-Ponce Y; Ibáñez-Escribano A; Gómez-Barrio A; Escario JA; Barigye SJ; Terán E; García-Jacas CR; Machado-Tugores Y; Nogal-Ruiz JJ; Arán-Redó VJ
    Future Med Chem; 2018 Apr; 10(8):863-878. PubMed ID: 29589477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Trichomonas vaginalis: treatment and resistance to nitroimidazoles].
    Vázquez F; José García M; Pérez F; Palacio V
    Enferm Infecc Microbiol Clin; 2001 Mar; 19(3):114-24. PubMed ID: 11333589
    [No Abstract]   [Full Text] [Related]  

  • 12. Metronidazole-resistant Trichomonas vaginalis.
    Forsgren A; Forssman L
    Br J Vener Dis; 1979 Oct; 55(5):351-3. PubMed ID: 315809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro susceptibility of Trichomonas vaginalis to metronidazole and treatment outcome in vaginal trichomoniasis.
    Müller M; Lossick JG; Gorrell TE
    Sex Transm Dis; 1988; 15(1):17-24. PubMed ID: 3258675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring the in vitro susceptibility of Trichomonas vaginalis to metronidazole: a disk broth method.
    Smith RF; Di Domenico A
    Sex Transm Dis; 1980; 7(3):120-4. PubMed ID: 6969450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of 5-nitroimidazole-resistant trichomonas vaginalis in Oviedo, Spain.
    Pérez S; Fernández-Verdugo A; Pérez F; Vázquez F
    Sex Transm Dis; 2001 Feb; 28(2):115-6. PubMed ID: 11234785
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of metronidazole-resistant Trichomonas vaginalis with tinidazole: case reports of three patients.
    Hager WD
    Sex Transm Dis; 2004 Jun; 31(6):343-5. PubMed ID: 15167642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of 2 g single dose of metronidazole, nimorazole and tinidazole in the treatment of vaginitis associated with Gardnerella vaginalis.
    Mohanty KC; Deighton R
    J Antimicrob Chemother; 1987 Mar; 19(3):393-9. PubMed ID: 3494725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tinidazole: a review of its antiprotozoal activity and therapeutic efficacy.
    Sawyer PR; Brogden RN; Pinder RM; Speight TM; Avery GS
    Drugs; 1976; 11(6):423-40. PubMed ID: 954609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic review of the literature on mechanisms of 5-nitroimidazole resistance in
    Graves KJ; Novak J; Secor WE; Kissinger PJ; Schwebke JR; Muzny CA
    Parasitology; 2020 Nov; 147(13):1383-1391. PubMed ID: 32729451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metronidazole and tinidazole in a single large dose for treating urogenital infections with Trichomonas vaginalis in men.
    Kawamura N
    Br J Vener Dis; 1978 Apr; 54(2):81-3. PubMed ID: 305809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.